Effect of Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Reduced Ejection Fraction

NCT02788747 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: 4 mg elamipretide
DRUG: 40 mg elamipretide
DRUG: Placebo

Sponsor

Stealth BioTherapeutics Inc.